Dendreon Corp  DNDN
Data as of 05-23-2013 12:22 PM CT
Last PriceDay ChangeVolume
$3.97
0.02 (0.38%)
893,520
Open PriceDay Range52-Wk Range
$3.90
3.98 - 3.86
7.94 - 3.69
Mkt Cap($mil)YieldAvg Volume
---
---
---
P/EP/SP/CF
-1.63
1.90
-2.41
 
 Stock Chart
Price Graph
 Key Stats
Morningstar Style BoxSmall GrowthStock TypeDistressed
IndustryBiotechnologySectorHealthcare
Market Cap $Mil--- Sales $Mil311
 Company Profile
What Does This Company Do?

Dendreon is a biotechnology firm focused on the discovery, development, and commercialization of novel cancer therapies. The company's only marketed product is prostate cancer treatment Provenge, the first active cellular immunotherapy for cancer to hit the market. Dendreon also has other oncology immunotherapies and small-molecule drug candidates in preclinical and early clinical development.

Address1301 2nd Avenue
 Suite 3200
 Seattle, WA, 98101
Phone1 206 256-4545
Websitehttp://www.dendreon.com
Employees1,050
Direct InvestmentNo
Dividend ReinvestmentNo
All quote data supplied by Morningstar Real-Time Data. Quotes for Nasdaq, NYSE and securities are delayed 20 minutes. © Copyright 2010 Morningstar, Inc.
Show Data Definitions
Become a Morningstar Premium Member. Enjoy our analyst picks and buy-sell opinions on 3,800 stocks, funds and ETFs. Learn more.

© Copyright 2013 Morningstar, Inc. All rights reserved. Morningstar, the Morningstar logo, Morningstar.com, Morningstar Tools are either trademark or service marks of Morningstar, Inc.
Past performance is no guarantee of future results.
Returns will vary and shares may be worth more or less than their original cost when sold.